Theriva Biologics reported progress in its VIRAGE2 Phase 2a trial for VCN-01, a cancer drug targeting metastatic pancreatic cancer, with enrollment expected to complete by Q4 2026 and initial data anticipated by Q3 2027. The company also completed the sale of its SYN-004 antibiotic enzyme portfolio to Biossil Labs for $350,000 upfront plus up to $91 million in milestones and royalties. Financially, Theriva had $8.5 million in cash as of September 30, 2026, providing a runway into Q1 2027. The VIRAGE2 trial aims to optimize VCN-01 dosing, potentially leading to pivotal Phase 3 trials, while ongoing discussions with the FDA continue for retinoblastoma treatment development.
Theriva Biologics' recent operational and financial update provides context for readers following biotech developments. For readers following the Health sector, here is Pluang's market snapshot as of Nov 12, 2026 19:11 WIB: among 150 priced US Health stocks, 91 rose and 53 fell today. Eli Lilly And Co (LLY) stood out with a price of USD 1,477.12 and a 1-day gain of +2.74%, contrasting with Inovio Pharmaceuticals Inc (INO) at USD 1.43 down 3.05%, and Hims and Hers Health Inc (HIMS) at USD 20.20 down 2.93%. Pluang order activity showed a stronger sell bias for HIMS (82% Sell) than INO (58% Sell).
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
Glider has introduced a global investing platform for tokenized stocks that operates permissionlessly, bypassing the SEC's Tokenized Securities Venues (TSVs) which 50 public companies recently rejected. Backed by major investors like a16z and Coinbas...
Tilray Brands announced that its subsidiaries 10 Barrel Brewing, Widmer Brothers Brewing, and Hop Valley Brewing are now the official craft beer partners of the Portland Trail Blazers. This partnership expands the availability of Oregon craft beers a...
Nexpu Ltd.'s subsidiary, Top Kingwin Hi Tech Inc., has finished delivering all 10,000 TK-D2C robots to Walkers Times International under a $4.8 million resale contract signed in 2025. The deliveries were completed in batches, with the final 5,000 uni...
